Aeglea BioTherapeutics AGLE reported its Q3 earnings results on Thursday, November 3, 2022 at 07:00 AM.
Here's what investors need to know about the announcement.
Aeglea BioTherapeutics beat estimated earnings by 17.39%, reporting an EPS of $-0.19 versus an estimate of $-0.23.
Revenue was down $1.23 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.04 which was followed by a 1.23% increase in the share price the next day.
To track all earnings releases for Aeglea BioTherapeutics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.